Loading…

Loading grant details…

Completed NON-SBIR/STTR RPGS NIH (US)

Molecular mechanisms of oral deficiencies in Down syndrome

$3.23M USD

Funder NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH
Recipient Organization New York University
Country United States
Start Date Sep 18, 2024
End Date Jun 30, 2025
Duration 285 days
Number of Grantees 1
Roles Principal Investigator
Data Source NIH (US)
Grant ID 11058191
Grant Description

Project summary Down syndrome (DS) is caused by trisomy of all or part of human chromosome 21 (Hsa21) and is the most common genetic cause of intellectual disability. DS predisposes affected individuals to a wide range of comorbidities that shorten their life expectancy and lower quality of life. People with DS are strongly predisposed

to develop autoimmune disorders, show consistent activation of interferon (IFN) responses, and produce significantly less saliva than healthy controls. These last set of features are shared with another syndrome, Sjogren’s Disease (SjD), an autoimmune disease affecting salivary (and lacrimal) glands resulting in reduced

saliva, elevated autoantibodies (SSA, SSB) in serum, and lymphocytic infiltration of the glands. In DS, there is a triplication of the interferon receptor (IFNR) gene cluster resulting in chronic interferon hyperactivity and inflammation. In SjD, patients exbibit not only salivary gland inflammation and elevated levels of type 1 IFN.

Because of the shorter life expectancy associated with DS and given that SjD predominantly affects middle-aged persons, this may have biased findings linking both conditions, although some case reports have described SjD in DS. Our preliminary data, obtained in our studies part of the parent grant, show that Dp16 mice hyposalivate,

indicating abnormal salivary gland function. The aim of this supplement is to address if DS is a condition that predisposes individuals to develop Sjogren’s-like disease. To address this, we will challenge the Dp16 mice, a well-known DS mouse model, with agonists of both toll-like receptors (TLR), particularly TLR7 and TLR8, which

we and others have been reported in salivary glands and in SjD, and interferon stimulation (e.g. DMXAA), and to test the ability of common blockers of IFN signaling, such as JAK inhibitors, to ameliorate inflammation and improve salivation. These studies enhance the goals of the parent award by assessing whether the salivary

glands in Dp16 mice are prone to developing an inflammatory response typical of SjD.

All Grantees

New York University

Advertisement
Apply for grants with GrantFunds
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant